Industries Market Research Reports

The year 2023 will begin with three disruptive forces already playing out. The first is inflationary pressure on wages. The global labor market is expected to remain tight due to aging workforces and stringent immigration policies. The COVID-19 pandemic’s impact on labor force turnover rates will keep price inflation higher than pre-pandemic l...

As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

Healthcare during the COVID-19 pandemic has undeniably seen some of its most significant changes. The growth of digital health was a silver lining, and enterprise IT solution providers and telehealth vendors saw tremendous growth during this time. They will continue to see the same in the coming years. Digital health continued to have a winning str...

Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are pr...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

19 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: Healthcare Data Analytics, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...

COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...